Name: UMIN ID:
Unique ID issued by UMIN | UMIN000032642 |
---|---|
Receipt number | R000037222 |
Scientific Title | Phase 2 study of S-1 and concurrent breath controlled intensity modulated radiation therapy for locally advanced unresectable pancreatic cancer. |
Date of disclosure of the study information | 2018/05/21 |
Last modified on | 2023/11/22 14:37:18 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2018/05/19 10:01:28 | ||
2 | Update | 2018/07/15 02:10:47 | Recruitment status |
|
3 | Update | 2018/11/18 12:26:00 | Organization1 Email1 Institutions |
|
4 | Update | 2018/11/18 12:27:32 | Recruitment status |
|
5 | Update | 2019/05/20 09:26:10 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
6 | Update | 2019/05/20 09:29:00 | Date of IRB Last follow-up date |
|
7 | Update | 2020/11/19 14:17:55 | Date of closure to data entry |
|
8 | Update | 2020/11/19 14:19:11 | Other related information |
|
9 | Update | 2021/05/20 09:10:23 | Other related information |
|
10 | Update | 2021/11/20 17:30:01 | Other related information |
|
11 | Update | 2022/11/21 10:23:32 | Other related information |
|
12 | Update | 2023/05/22 09:11:00 | Recruitment status Other related information Other related information |
|
13 | Update | 2023/11/22 14:37:18 | Number of participants that the trial has enrolled |